hydroflumethiazide has been researched along with meprobamate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Beltermann, R | 1 |
| Ashrafian, LA; Berstein, LM; Chepik, OF; Gamajunova, VB; Kovalevskij, AJ; Maximov, SJ; Tchernobrovkina, AE; Thijssen, JH; Tsyrlina, EV; Turkevitch, EA; Vasilyev, DA | 1 |
1 review(s) available for hydroflumethiazide and meprobamate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for hydroflumethiazide and meprobamate
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
[Therapeutic experiences with Praemenstron in the premenstrual syndrome].
Topics: Adult; Drug Combinations; Dysmenorrhea; Female; Humans; Hydroflumethiazide; Menorrhagia; Meprobamate; Middle Aged; Premenstrual Syndrome; Progesterone | 1974 |
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer.
Topics: Aged; DNA Damage; Drug Combinations; Endometrial Neoplasms; Estradiol; Female; Humans; Hydroflumethiazide; Meprobamate; Middle Aged; Postmenopause; Progesterone | 2003 |